MFDS — authorised 22 August 1962
- Marketing authorisation holder: WYETH AYERST
- Status: likely_approved
MFDS authorised Grifulvin V on 22 August 1962
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 22 August 1962.
WYETH AYERST holds the South Korean marketing authorisation.